ParkinsonFranceV1, Hal, Corpus, bibRecord, 000B25

The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease

Identifieur interne : 000B25 ( Hal/Corpus ); précédent : 000B24; suivant : 000B26

The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease

Auteurs : N. Turle-Lorenzo ; B. Maurin ; C. Puma ; C. Chezaubernard ; P. Morain ; C. Baunez ; A. Nieoullon ; M. Amalric

Source :

Journal of Pharmacology and Experimental Therapeutics [ 0022-3565 ] ; 2006.

RBID : Hal:hal-00306729
Url:

https://hal.archives-ouvertes.fr/hal-00306729

Links to Exploration step

Hal:hal-00306729

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease</title>
<author><name sortKey="Turle Lorenzo, N" sort="Turle Lorenzo, N" uniqKey="Turle Lorenzo N" first="N." last="Turle-Lorenzo">N. Turle-Lorenzo</name>
</author>
<author><name sortKey="Maurin, B" sort="Maurin, B" uniqKey="Maurin B" first="B." last="Maurin">B. Maurin</name>
</author>
<author><name sortKey="Puma, C" sort="Puma, C" uniqKey="Puma C" first="C." last="Puma">C. Puma</name>
</author>
<author><name sortKey="Chezaubernard, C" sort="Chezaubernard, C" uniqKey="Chezaubernard C" first="C." last="Chezaubernard">C. Chezaubernard</name>
</author>
<author><name sortKey="Morain, P" sort="Morain, P" uniqKey="Morain P" first="P." last="Morain">P. Morain</name>
</author>
<author><name sortKey="Baunez, C" sort="Baunez, C" uniqKey="Baunez C" first="C." last="Baunez">C. Baunez</name>
</author>
<author><name sortKey="Nieoullon, A" sort="Nieoullon, A" uniqKey="Nieoullon A" first="A." last="Nieoullon">A. Nieoullon</name>
<affiliation><hal:affiliation type="laboratory" xml:id="struct-199397" status="VALID">  <idno type="IdRef">149374186</idno>
  <idno type="RNSR">201220316K</idno>
  <orgName>Institut de Biologie du Développement de Marseille</orgName>
  <orgName type="acronym">IBDM</orgName>
  <date type="start">2012</date>
  <desc>    <address>      <addrLine>Case 907 - Parc Scientifique de Luminy 13288 Marseille Cedex 9</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.ibdm.univ-mrs.fr</ref>
  </desc>
  <listRelation>    <relation name="UMR7288" active="#struct-303623" type="direct"></relation>
    <relation name="UMR7288" active="#struct-198056" type="direct"></relation>
    <relation name="UMR7288" active="#struct-441569" type="direct"></relation>
    <relation active="#struct-5033" type="direct"></relation>
  </listRelation>
<tutelles><tutelle name="UMR7288" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID">  <idno type="IdRef">026388278</idno>
  <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
  <orgName type="acronym">INSERM</orgName>
  <desc>    <address>      <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.inserm.fr</ref>
  </desc>
</org>
</tutelle>
<tutelle name="UMR7288" active="#struct-198056" type="direct"><org type="institution" xml:id="struct-198056" status="VALID"><idno type="IdRef">15863621X</idno>
<idno type="ISNI">0000 0001 2176 4817</idno>
<orgName>Aix Marseille Université</orgName>
<orgName type="acronym">AMU</orgName>
<date type="start">2012-01-01</date>
<desc><address><addrLine>Aix-Marseille UniversitéJardins du Pharo58 Boulevard Charles Livon13284 Marseille cedex 7</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-amu.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR7288" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"><idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc><address><country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-5033" type="direct"><org type="institution" xml:id="struct-5033" status="OLD"><idno type="IdRef">026402882</idno>
<orgName>Université de la Méditerranée - Aix-Marseille 2</orgName>
<date type="start">1969</date>
<date type="end">2011</date>
<desc><address><addrLine>58, boulevard Charles Livon - 13284 Marseille cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univmed.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Amalric, M" sort="Amalric, M" uniqKey="Amalric M" first="M." last="Amalric">M. Amalric</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00306729</idno>
<idno type="halId">hal-00306729</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00306729</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-00306729</idno>
<date when="2006">2006</date>
<idno type="wicri:Area/Hal/Corpus">000B25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease</title>
<author><name sortKey="Turle Lorenzo, N" sort="Turle Lorenzo, N" uniqKey="Turle Lorenzo N" first="N." last="Turle-Lorenzo">N. Turle-Lorenzo</name>
</author>
<author><name sortKey="Maurin, B" sort="Maurin, B" uniqKey="Maurin B" first="B." last="Maurin">B. Maurin</name>
</author>
<author><name sortKey="Puma, C" sort="Puma, C" uniqKey="Puma C" first="C." last="Puma">C. Puma</name>
</author>
<author><name sortKey="Chezaubernard, C" sort="Chezaubernard, C" uniqKey="Chezaubernard C" first="C." last="Chezaubernard">C. Chezaubernard</name>
</author>
<author><name sortKey="Morain, P" sort="Morain, P" uniqKey="Morain P" first="P." last="Morain">P. Morain</name>
</author>
<author><name sortKey="Baunez, C" sort="Baunez, C" uniqKey="Baunez C" first="C." last="Baunez">C. Baunez</name>
</author>
<author><name sortKey="Nieoullon, A" sort="Nieoullon, A" uniqKey="Nieoullon A" first="A." last="Nieoullon">A. Nieoullon</name>
<affiliation><hal:affiliation type="laboratory" xml:id="struct-199397" status="VALID">  <idno type="IdRef">149374186</idno>
  <idno type="RNSR">201220316K</idno>
  <orgName>Institut de Biologie du Développement de Marseille</orgName>
  <orgName type="acronym">IBDM</orgName>
  <date type="start">2012</date>
  <desc>    <address>      <addrLine>Case 907 - Parc Scientifique de Luminy 13288 Marseille Cedex 9</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.ibdm.univ-mrs.fr</ref>
  </desc>
  <listRelation>    <relation name="UMR7288" active="#struct-303623" type="direct"></relation>
    <relation name="UMR7288" active="#struct-198056" type="direct"></relation>
    <relation name="UMR7288" active="#struct-441569" type="direct"></relation>
    <relation active="#struct-5033" type="direct"></relation>
  </listRelation>
<tutelles><tutelle name="UMR7288" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID">  <idno type="IdRef">026388278</idno>
  <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
  <orgName type="acronym">INSERM</orgName>
  <desc>    <address>      <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.inserm.fr</ref>
  </desc>
</org>
</tutelle>
<tutelle name="UMR7288" active="#struct-198056" type="direct"><org type="institution" xml:id="struct-198056" status="VALID"><idno type="IdRef">15863621X</idno>
<idno type="ISNI">0000 0001 2176 4817</idno>
<orgName>Aix Marseille Université</orgName>
<orgName type="acronym">AMU</orgName>
<date type="start">2012-01-01</date>
<desc><address><addrLine>Aix-Marseille UniversitéJardins du Pharo58 Boulevard Charles Livon13284 Marseille cedex 7</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-amu.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR7288" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"><idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc><address><country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-5033" type="direct"><org type="institution" xml:id="struct-5033" status="OLD"><idno type="IdRef">026402882</idno>
<orgName>Université de la Méditerranée - Aix-Marseille 2</orgName>
<date type="start">1969</date>
<date type="end">2011</date>
<desc><address><addrLine>58, boulevard Charles Livon - 13284 Marseille cedex 07</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univmed.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Amalric, M" sort="Amalric, M" uniqKey="Amalric M" first="M." last="Amalric">M. Amalric</name>
</author>
</analytic>
<series><title level="j">Journal of Pharmacology and Experimental Therapeutics</title>
<idno type="ISSN">0022-3565</idno>
<imprint><date type="datePub">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<hal api="V3">          <titleStmt>            <title xml:lang="en">The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease</title>
            <author role="aut">              <persName>                <forename type="first">N.</forename>
                <surname>Turle-Lorenzo</surname>
              </persName>
              <idno type="halauthorid">333282</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">B.</forename>
                <surname>Maurin</surname>
              </persName>
              <idno type="halauthorid">333283</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">C.</forename>
                <surname>Puma</surname>
              </persName>
              <idno type="halauthorid">333284</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">C.</forename>
                <surname>Chezaubernard</surname>
              </persName>
              <idno type="halauthorid">333285</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">P.</forename>
                <surname>Morain</surname>
              </persName>
              <idno type="halauthorid">333286</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">C.</forename>
                <surname>Baunez</surname>
              </persName>
              <idno type="halauthorid">150614</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">A.</forename>
                <surname>Nieoullon</surname>
              </persName>
              <idno type="halauthorid">107310</idno>
              <affiliation ref="#struct-199397"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">M.</forename>
                <surname>Amalric</surname>
              </persName>
              <idno type="halauthorid">117258</idno>
            </author>
            <editor role="depositor">              <persName>                <forename>Lydia</forename>
                <surname>Nelsom</surname>
              </persName>
              <email type="md5">bba8ce8b7a76814561866cfe35712816</email>
              <email type="domain">univ-amu.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>            <edition n="v1" type="current">              <date type="whenSubmitted">2008-07-28 14:37:05</date>
              <date type="whenModified">2008-07-28 14:37:05</date>
              <date type="whenReleased">2008-07-28 14:37:05</date>
              <date type="whenProduced">2006</date>
            </edition>
            <respStmt>              <resp>contributor</resp>
              <name key="112288">                <persName>                  <forename>Lydia</forename>
                  <surname>Nelsom</surname>
                </persName>
                <email type="md5">bba8ce8b7a76814561866cfe35712816</email>
                <email type="domain">univ-amu.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>            <distributor>CCSD</distributor>
            <idno type="halId">hal-00306729</idno>
            <idno type="halUri">https://hal.archives-ouvertes.fr/hal-00306729</idno>
            <idno type="halBibtex">turlelorenzo:hal-00306729</idno>
            <idno type="halRefHtml">Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2006, 319 (2), pp.914-923</idno>
            <idno type="halRef">Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2006, 319 (2), pp.914-923</idno>
          </publicationStmt>
          <seriesStmt>            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-AMU">Aix Marseille Université</idno>
          </seriesStmt>
          <notesStmt>            <note type="audience" n="1">Not set</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>            <biblStruct>              <analytic>                <title xml:lang="en">The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease</title>
                <author role="aut">                  <persName>                    <forename type="first">N.</forename>
                    <surname>Turle-Lorenzo</surname>
                  </persName>
                  <idno type="halauthorid">333282</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">B.</forename>
                    <surname>Maurin</surname>
                  </persName>
                  <idno type="halauthorid">333283</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">C.</forename>
                    <surname>Puma</surname>
                  </persName>
                  <idno type="halauthorid">333284</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">C.</forename>
                    <surname>Chezaubernard</surname>
                  </persName>
                  <idno type="halauthorid">333285</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">P.</forename>
                    <surname>Morain</surname>
                  </persName>
                  <idno type="halauthorid">333286</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">C.</forename>
                    <surname>Baunez</surname>
                  </persName>
                  <idno type="halauthorid">150614</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">A.</forename>
                    <surname>Nieoullon</surname>
                  </persName>
                  <idno type="halauthorid">107310</idno>
                  <affiliation ref="#struct-199397"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">M.</forename>
                    <surname>Amalric</surname>
                  </persName>
                  <idno type="halauthorid">117258</idno>
                </author>
              </analytic>
              <monogr>                <idno type="halJournalId" status="VALID">15999</idno>
                <idno type="issn">0022-3565</idno>
                <idno type="eissn">1521-0103</idno>
                <title level="j">Journal of Pharmacology and Experimental Therapeutics</title>
                <imprint>                  <publisher>American Society for Pharmacology and Experimental Therapeutics</publisher>
                  <biblScope unit="volume">319</biblScope>
                  <biblScope unit="issue">2</biblScope>
                  <biblScope unit="pp">914-923</biblScope>
                  <date type="datePub">2006</date>
                </imprint>
              </monogr>
            </biblStruct>
          </sourceDesc>
          <profileDesc>            <langUsage>              <language ident="en">English</language>
            </langUsage>
            <textClass>              <classCode scheme="halDomain" n="sdv.bc">Life Sciences [q-bio]/Cellular Biology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
            </textClass>
          </profileDesc>
        </hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B25 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000B25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:hal-00306729
   |texte=   The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease

The dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri